Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiki Fukasawa

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
JAMA Oncology|December 26, 2025
Concerns in the Propensity Score-Matched AnalysisYoshihide Inayama, Toshiki Fukasawa, Koji Yamanoi
Value in Health Regional Issues|February 12, 2025
Effects of Reimbursement Add-On Policies on Trastuzumab and Bevacizumab Biosimilar Adoption in a Japanese Oncology SettingHiroaki Mamiya, Toshiki Fukasawa, Koji Kawakami
Pharmacoepidemiology and Drug Safety|May 18, 2026
Resumption of Antiplatelet Therapy After Burr-Hole Surgery and Recurrence in Patients With Chronic Subdural Hematoma: A Target Trial EmulationTakayuki Anno, Toshiki Fukasawa, Koji Kawakami
Journal of Pharmaceutical Policy and Practice|March 2, 2026
Financial reimbursement incentives in the use of biosimilars for rheumatoid arthritis in JapanHiroaki Mamiya, Toshiki Fukasawa, Koji Kawakami
Pharmacoepidemiology and Drug Safety|July 3, 2026
Effectiveness of Metformin in Preventing Colorectal Cancer Among Japanese Patients With Type 2 Diabetes: A Target Trial EmulationShunsuke Hiroki, Toshiki Fukasawa, Munenori Honda, et al.
Bone|June 2, 2025
Methodological concerns, implausibly early fracture reduction, and potential outcome misclassification: Comment on "Comparative effectiveness of romosozumab versus teriparatide for fracture prevention: A new-user, active comparator design"Soichiro Masuda, Toshiki Fukasawa, Shuichi Matsuda, et al.
Journal of Epidemiology|March 5, 2019
Utility of a Specific Health Checkup Database Containing Lifestyle Behaviors and Lifestyle Diseases for Employee Health Insurance in JapanToshiki Fukasawa, Nanae Tanemura, Shinya Kimura, et al.
Journal of Medical Virology|September 15, 2025
Effectiveness of Metformin in Preventing Herpes Zoster Among Japanese Patients With Type 2 Diabetes: A Target Trial EmulationShunsuke Hiroki, Toshiki Fukasawa, Kasumi Yokogawa, et al.
Modern Rheumatology|December 26, 2024
Comparative renoprotective effectiveness of allopurinol and febuxostat among hyperuricemic patients with preserved kidney functionAtsushi Takayama, Toshiki Fukasawa, Masato Takeuchi, et al.
Pharmacoepidemiology and Drug Safety|May 25, 2026
Letter to the Editor Regarding "Safety of Short-Term Trimethoprim-Sulfamethoxazole Use for Uncomplicated Cystitis: A Nationwide Retrospective Cohort Study"Toshiki Fukasawa, Hisashi Urushihara, Takayuki Okura, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
JAMA Oncology|December 26, 2025
Concerns in the Propensity Score-Matched AnalysisYoshihide Inayama, Toshiki Fukasawa, Koji Yamanoi
Value in Health Regional Issues|February 12, 2025
Effects of Reimbursement Add-On Policies on Trastuzumab and Bevacizumab Biosimilar Adoption in a Japanese Oncology SettingHiroaki Mamiya, Toshiki Fukasawa, Koji Kawakami
Pharmacoepidemiology and Drug Safety|May 18, 2026
Resumption of Antiplatelet Therapy After Burr-Hole Surgery and Recurrence in Patients With Chronic Subdural Hematoma: A Target Trial EmulationTakayuki Anno, Toshiki Fukasawa, Koji Kawakami
Journal of Pharmaceutical Policy and Practice|March 2, 2026
Financial reimbursement incentives in the use of biosimilars for rheumatoid arthritis in JapanHiroaki Mamiya, Toshiki Fukasawa, Koji Kawakami
Pharmacoepidemiology and Drug Safety|July 3, 2026
Effectiveness of Metformin in Preventing Colorectal Cancer Among Japanese Patients With Type 2 Diabetes: A Target Trial EmulationShunsuke Hiroki, Toshiki Fukasawa, Munenori Honda, et al.
Bone|June 2, 2025
Methodological concerns, implausibly early fracture reduction, and potential outcome misclassification: Comment on "Comparative effectiveness of romosozumab versus teriparatide for fracture prevention: A new-user, active comparator design"Soichiro Masuda, Toshiki Fukasawa, Shuichi Matsuda, et al.
Journal of Epidemiology|March 5, 2019
Utility of a Specific Health Checkup Database Containing Lifestyle Behaviors and Lifestyle Diseases for Employee Health Insurance in JapanToshiki Fukasawa, Nanae Tanemura, Shinya Kimura, et al.
Journal of Medical Virology|September 15, 2025
Effectiveness of Metformin in Preventing Herpes Zoster Among Japanese Patients With Type 2 Diabetes: A Target Trial EmulationShunsuke Hiroki, Toshiki Fukasawa, Kasumi Yokogawa, et al.
Modern Rheumatology|December 26, 2024
Comparative renoprotective effectiveness of allopurinol and febuxostat among hyperuricemic patients with preserved kidney functionAtsushi Takayama, Toshiki Fukasawa, Masato Takeuchi, et al.
Pharmacoepidemiology and Drug Safety|May 25, 2026
Letter to the Editor Regarding "Safety of Short-Term Trimethoprim-Sulfamethoxazole Use for Uncomplicated Cystitis: A Nationwide Retrospective Cohort Study"Toshiki Fukasawa, Hisashi Urushihara, Takayuki Okura, et al.
Pageof 7